Diverse asthma treatment pipeline presents major investment opportunity – Pharmaceutical Processing


Pharmaceutical Processing

Diverse asthma treatment pipeline presents major investment opportunity
Pharmaceutical Processing
The active and diverse treatment pipeline for asthma boasts a striking level of innovation, with many first-in-class products representing significant investment opportunities, says business intelligence provider GBI Research. The company's latest

View full post on asthma – Google News

Diverse Asthma Treatment Pipeline Presents Major Investment Opportunity, says … – Drug Discovery & Development

Diverse Asthma Treatment Pipeline Presents Major Investment Opportunity, says
Drug Discovery & Development
The company's latest report* states that while asthma therapy development is dominated by small molecule compounds, with 156 products representing 67% of the pipeline, the research and development landscape has moved towards biologics on an …

View full post on asthma – Google News

Recently Released Market Study: R&D Trends: Asthma – Extensive Investment in … – SBWire (press release)

Recently Released Market Study: R&D Trends: Asthma – Extensive Investment in
SBWire (press release)
Boston, MA — (SBWIRE) — 07/26/2012 — Datamonitor identified 139 products in development for asthma in 2012. In the near term Datamonitor expects that there will be little change in treatment regimens but strong innovation is seen in earlier stages

View full post on asthma – Google News